CHI to Celebrate the 10th Anniversary of PEGS - the essential protein & antibody engineering summit

Over 1,600 scientists will convene at this annual event to celebrate the evolution of biologics, and the generation, characterization, and clinical application of proteins.
Spread the Word
Listed Under

* Antibody
* Protein-engineering
* Pharma
* Biologics
* Biopharm

* Biotech
* Science

* Events

Jan. 31, 2014 - PRLog -- This Spring, Cambridge Healthtech Institute (CHI) will host its 10th Annual “PEGS - the essential protein engineering summit” at the Seaport World Trade Center in Boston, Massachusetts.

Over 1,600 participants will gather in Boston’s historic Seaport District for open forum discussions and collaboration in the areas of protein & antibody engineering, oncology, expression, analytical, safety, and - new this year- bioprocessing and therapeutics programming. The continued success of PEGS is driven by the growth in biologics worldwide, the quality of scientific programming presented and valuable networking opportunities.

A plenary keynote session will kick off the week with presentations from industry leaders Bahija Jallal, Ph.D., Executive Vice President of MedImmune, and George D. Yancopoulos, M.D., Ph.D., President, Regeneron Laboratories; CSO, Regeneron Pharmaceuticals, Inc.

The summit will offer over 375 presentations within 7 topic-focused streams comprised of 20 conferences, 17 short courses, over 100 exhibiting companies, and nearly 200 scientific research posters on display. Delegates can create their own agenda by moving between the tracks and choosing the sessions that best fit their research and networking needs.

Tools and Winning Strategies for Creating the Next Generation of Biologics

Lessons Learned from Recent Challenges & Advances in Antibody Therapeutics

Advancing Development of Biologics through Novel Targets and Constructs

Meeting the Challenge to Improve Throughput and Quality

Overcoming Challenges in Characterization, Biophysical Analysis and Aggregation

Immunogenicity Assays, PK/PD and Control of Immunogenicity for Safety and Efficacy

Ensuring Effective and Efficient Scale-Up and Production of Antibody-Based Biologics

Exhibit and sponsorship opportunities are available. For details, contact Carol Dinerstein, 781-972-5471,

Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi,

For more information, visit

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group. For more information, visit

For more information:
Nicole Proulx
Cambridge Healthtech Institute

Nicole Proulx
Email:*** Email Verified
Tags:Antibody, Protein-engineering, Pharma, Biologics, Biopharm
Industry:Biotech, Science
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Daily News
Weekly News

Like PRLog?
Click to Share